chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt tired; little achy; on and off headaches. On Nov 29th, I had a stroke. Not sure if it is related to the vaccine but thought I should report it.
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Nov-2021 at 3:07 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 19-Nov-2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication was reported. No concomitant medication was reported.  The vial undergone temperature excursions for 1 month. The vial was in frozen state at the time of the excursion (Vials in question stored in a super cold Freezer) and minimum reached temperatures was negative 82 degrees Fahrenheit. The patient was given dose from vial that was stored in an ultracold freezer which was colder than it should have been. The vial was moved from freezer to refrigerator on 19-Nov-2021, when the Moderna Covid-19 vials went from the super cold freezer to the refrigerator. The vials were returned to the freezer/refrigerator or maintained at room temperature.  The reporter stated that total 70 vials were still in the ultra-cold freezer and 8 vials were in the refrigerator. No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursions were reported. Total 280 patients received Moderna Covid 19 stored at minus 82 degrees Fahrenheit.   This case was linked to MOD-2021-402935 (Patient Link).
No adverse effects were reported.; Patient was administered improperly stored VARIVAX; Information has been received from a medical assistant, concerning a patient of unknown age and gender. The patient's pertinent medical history, previously drug reactions, allergies, concurrent conditions and concomitant medication were not reported.      On 14-JUN-2019, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot number R035222 with expiration date in 04-DEC-2020 (strength, anatomical location, dose and route of administration were not provided) for prophylaxis, that was reconstituted with sterile diluent (DILUENT MRK) (strength, dose, lot number, expiration date and route of administration were not provided) (it was not reported if the sterile diluent (DILUENT MRK) used had an excursion).   The varicella virus vaccine live (oka/merck) (VARIVAX) was stored at a temperature range of -9 degrees Celsius (°C) to 8°C (-3°C), for the time frame of 3 hours and 39 minutes. There was no previous temperature excursion and the call was because of a data logger.   No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA008695: US-009507513-1906USA008644: US-009507513-1906USA008643: US-009507513-1906USA008722: US-009507513-1906USA008662: US-009507513-1906USA008721: US-009507513-1906USA008724: US-009507513-1906USA008725:
His platelets dropped 40 points to 123 thousand; This is a spontaneous report from contactable nurse. This nurse (patient's mother) reported for her 22-year-old son (patient).  A 22-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 21Aug2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Patient age at vaccination was 22-year-old. Medical history included when he was little, like 11-years-old, he had issues with an allergic reaction, it was hives, and his platelets dropped but he had never had any problems with that. He had played contact sports, like hockey, and was fine. He had the disease, COVID, 10 months ago (Oct2020) and it was just like a bad cold, the worst part for him was that he lost his taste and his smell for 3 weeks. She obviously checked his platelets after he had COVID and everything was fine, it was 140 to 143 which was not that bad but it did drop a little. The patient's concomitant medications were not reported.  Due to patient had history of COVID-19, reporter's husband who was a physician monitored patient's antibodies because obviously the antibodies were better than the vaccine. And up until 3 weeks ago he was negative for IVGG. They made the choice to get the Pfizer COVID vaccine. The hematologist said to check her son's platelets before and after he had the COVID vaccine, like 48 hours to 72 hours afterwards because it may drop between that time period. They tested with two different labs. Patient's level was 168, which was before the COVID vaccine and which was a low normal and the other lab said it was 163. Reporter was fine with that since it was normal. So patient got the COVID vaccine. Also, before her son was tested for COVID with a blood test and a PCR to make sure that he didn't have COVID. They did his blood work yesterday (24Aug2021) and his platelets dropped 40 points to 123 thousand. Outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 in 01/2023. I contacted my provider and got a prescription for PAXLOVID. It made me sick after two days, so I stopped taking. I took over the counter medicine to help me with my symptoms. I had chest congestion and nasal congestion. I had trouble with a dry unproductive cough. I got a prescription for a steroid and an antibiotic, and the cough finally got better. In 04/2023, I got sick again with chest congestion. I got another prescription for steroids and antibiotic. As of today, I am feeling better. In a couple of weeks, I am to contact my doctor and get a referral for a pulmonologist. When I lay down, I feel my heart beating. If I get up to fast, I notice my heartbeat goes up quickly. I do get tired very easily.
Patient accidentally received dose 2 Pfizer instead of Moderna. Education provided to patient by RN and Mixteco translator, follow up telehealth appt set up for patient.
Fever, chills, chest pain lasting 36 hours, hypertension lasting 48 hours, severe lymph node pain and swelling, nausea
Blurred vision, chest tightness - like "asthma" right hand tingling, headache did not take anything for it. Next day felt weak but no symptoms.
6 hours after I got the vaccine I started getting a headache, followed quickly by horrible body chills and then horrible body aches. My temperature about an hour later was 105. I took 1000 mg of Tylenol right away and put a cold rag on my head and tried to go to sleep. A couple hours later my fever started breaking, when it was 102.7 I was a sweaty mess and extremely hot and puked a lot.  My fever and other symptoms went away within about 7 hours after my fever started breaking.
Patient believes vaccine caused pripheral neuropathy and left hip joint deterioration as long term sequelae.  Believes vaccine caused problem within those any one shot.
Red, slightly raised , round lump at injection site, approximately 2 inches.  Warm to touch, hard, and itchy.
warm to touch; a bit itchy; a lump, on the injection site, muscle of her right arm / 1 to 2 inches in size lump and tender when touched; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (a bit itchy) and VACCINATION SITE SWELLING (a lump, on the injection site, muscle of her right arm / 1 to 2 inches in size lump and tender when touched) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypothyroidism. Concomitant products included GLIPIZIDE and METFORMIN for Diabetes, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) and LISINOPRIL for Hypothyroidism.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (a bit itchy) and VACCINATION SITE SWELLING (a lump, on the injection site, muscle of her right arm / 1 to 2 inches in size lump and tender when touched). At the time of the report, VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (a bit itchy) and VACCINATION SITE SWELLING (a lump, on the injection site, muscle of her right arm / 1 to 2 inches in size lump and tender when touched) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: event outcome updated
severe vomiting and exhaustion for two days resulting in diabetic ketoacidosis, and death on 9/28/2021
See attached emergency report. Low BP 51/29 / Low heart rate / decreased respirations. Treated with Epinephrine 0.3mg x 1 IM and Diphenhydramine IM 50mg.
I developed skin irritation and rash on my chest, neck,  torso, arms, back, legs, pelvic region Thursday evening, three days after receiving vaccine. This include severe itching, redness, inflammation, and visible red bumps. The symptoms are not getting better, so I visited  the Dr.. I was tested for COVID to make sure I was not exposed after the vaccine, and the results were negative for COVID. She prescribed me prescription strength cream, because the Cortisone cream, in combination with Zyrtec and Benadryl  are not working. She did not want to give me anything stronger due to concerns of hindering the effect of the vaccine. It appears to be a mild allergic reaction, but is extremely unpleasant. I cannot stop scratching no matter how hard a try and it is all over my body.
Patent called stating on 9/7/2021 afternoon began having body aches. Woke the next day with headache and eyes hurt rash on arms and belly, sweats and chills. Unsure if he has a fever. Today 9/9/2021 rash is gone but continues with headache and eyes hurt, especially if he turns his head or coughs. States does not feel as though he is sick with a cough, though Taking tylenol with some relief No difficulty breathing or swelling. patient did not have any symptoms with previous two vaccines. Plan is to monitor over the next 24 hours if symptoms worsen or do not improve be seen by pcp or urgent care.
At approximately 11:45pm on 1/13/2021 I experienced chills.  My teeth were chattering and my body shook because I was so cold.  This lasted for about 30 minutes.  No fever and no other symptoms.   Morning of 1/14/2021 my head feels heavy.  Otherwise, no other symptoms.
HEART ATTACKS; This spontaneous report received from a consumer via a company representative via social media concerned multiple male patients. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patients was athletes. The patient's received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin was not reported, batch number: Unknown, expiry: Unknown) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the male athletes had heart attacks. The reporter stated that " look at all the male athletes having heart attacks". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of heart attacks was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20220946006, 20220946018 and 20220948144.; Sender's Comments: V0: 20220948266 -covid-19 vaccine ad26.cov2.s-Heart attacks. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.
The day after receiving the injection, I can't move my arm.  The pain is excruciating and I have no grip strength in my left hand/arm.  I see doctor on Monday the 8th.  He explains that the injection was misplaced in my shoulder and prescribes Meloxicam 15 mg tablet, once a day.  Continue with Meloxicam for month, contact him if no improvement after 2 weeks.
Headaches, low grade temp 100 degrees, neck pain, flu-like symptoms. Patient was treated by her family.
Crying, limp, weak, pale, fever, vomiting large amount, close to unresponsive about 50 minutes. Fever 102. Went to ER - given Tylenol, observed - sent next day better.
Patient called pharmacy 1/13/20 1PM stating she had hives about 45 minutes after receiving flu vaccine. She treated w/ oral benadryl and the hives subsided. She still had some hives at time of call, but said she was planning to take another dose of Benadryl.
Pt developed clinical varicella on 1/31/00. Pt also had antecedent macular exanthem on 1/25/00.
3DEC98 c/o h/a, n/v;4DEC98 returned to school;
Had strong chills and trembling for several hours followed by overheating. Felt nauseous but did not throw up. Lasted a little over 24 hours.
tingling in her lips; hacking cough which got worse and she felt hoarse; arm was red around two inches in diameter around the site of injetion; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling in her lips), COUGH (hacking cough which got worse and she felt hoarse) and VACCINATION SITE ERYTHEMA (arm was red around two inches in diameter around the site of injetion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PARAESTHESIA ORAL (tingling in her lips), COUGH (hacking cough which got worse and she felt hoarse) and VACCINATION SITE ERYTHEMA (arm was red around two inches in diameter around the site of injetion). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PARAESTHESIA ORAL (tingling in her lips) and COUGH (hacking cough which got worse and she felt hoarse) was resolving and VACCINATION SITE ERYTHEMA (arm was red around two inches in diameter around the site of injetion) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant drug information was not provided. Treatment included Tylenol and cough drops. It was still red around the injection site as of 01-Feb-2021. It was also reported that most of her symptoms improved over the next 4 days.   Reporter did not allow further contact
Mild pain, moderate tenderness, redness and mild swelling below injection site noted the day after vaccination.  Mild feeling of malaise, headache and body aches for 1-2 days following vaccination.
After my first shot in the left arm about 2 weeks after the shot I got a red, raised, warm, itchy rash. It lasted for about 3 days. I used hydrocortizone cream on it a few times and it went away After my second shot in the right arm. I got the same thing after 3 days, but it was not as large of an area as the first shot was.
had recurrent Shingles outbreaks even after receiving the Shingrex vaccine / has completed vaccine series in the past/Suspected vaccination failure; had recurrent Shingles outbreaks even after receiving the Shingrex vaccine / has completed vaccine series in the past; This case was reported by a physician and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional case details were reported as follows: The case was reported by the patient. Age at vaccination was not reported. A patient who had recurrent Shingles outbreaks even after receiving the Shingrex vaccine.  The reporter had asked if she could receive the Shingrix vaccine again ( twice), if she had completed her vaccine series in the past. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory confirmation were unknown at the time of reporting. Consent to follow up was granted.
pt recvd vax & devel low grade temp; vomiting, headache & redness at inject site; after 48 hrs, 2 1/2 inches redness at inject site;
03/02/23 presents to ED for "shortness of breath". PMHx of "dementia, hypothyroidism"
Patient began to have seizure like events of eye twitching with body stiffening the day after vaccines.
ER visit 01/23/05; 9 days @ hospital.  No coordination of limbs, dble vision, nausea, weakness-overall lt. side leg and arm and rt. side of face.  Inability to swallow, walk or sit up w/o help.   Treatment-none.  Rehab, PT, OT, f/u PT after hopitalization. Per follow up report-Right side of face numb.  Weakness in extremities.
This subject is a 32 year old female patient who was diagnosed with having Type II Diabetes Mellitus, on 10/25/02, approximately one year after receiving a dose of MENOMUNE A/C/Y/W-135, lot number UB034AA, given IM in the left arm on 11/06/2001. The patient was involved in a MTA-09 Adult Meningitis Study at this time. The subject was diagnosed with diabetes by lab results, no other symptoms or adverse events were reported. On 12/11/02, her glucose was 272 and GHb AlC was 10.2. And on 10/29/02, her glucose was 305 and her GHb AlC was 10.4. The patient was started on 500mg of Glucophage on 10/25/02. The patient had gestational diabetes in June 1998 and again in April 2000. She recovered from this after delivery. The patient has a history of asthma, hyperlipidemia and allergic rhinitis. At the time of vaccination, the patient was taking Lipitor, Maxalt MLT, Compazine, Tylenol and Aleve for migraines. The patient was also taking Keflex for an infected finger. The event of Type II Diabetes mellitus was reported by the investigator as unrelated to the study vaccine. (OMIC).
Sore arm for 24 hours; This is a spontaneous report from a non-contactable other healthcare professional. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 20Apr2021 at 09:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On an unknown date in 2021 the patient experienced sore arm for 24 hours. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event sore arm for 24 hours was recovered on an unknown date in April2021.   No follow-up attempts are possible. No further information is expected.
received both doses of the Pfizer covid vaccine early on and they all got covid 19; received both doses of the Pfizer covid vaccine early on and they all got covid 19; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 5 patients. This is the 3rd of five reports.   A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), 1st dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose, 2nd dose via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received both doses of the Pfizer COVID vaccine early on and the patient got COVID 19 on an unspecified date. The outcome of the event was unknown.   The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101133918 Same Reporter/Drug/AE, Different Patient
On 5/16/2021 11 year old was given Pfizer .3 ml - 1st dose On 6/4/21 11 year old was given Pfizer .3 ml -2nd dose
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old male patient received BNT162b2 (BNT162B2), on 16Dec2021 as dose number unknown, single (Batch/Lot number: unknown), in left arm, on 10Apr2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 48 years, in left arm and on 01May2022 as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "Mild asthma" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: COVID-19 (medically significant) with onset 18Mar2022, outcome "recovering", DRUG INEFFECTIVE (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: After a negative test on the day after completing the Paxlovid; Positive, notes: I had a positive athome Covid test a week after the final Paxlovid dose. Therapeutic measures were taken as a result of covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
bradycardia (HR as low as 40's), variable BP, dizziness, fever, diffuse body aches, cough, extreme fatigue, chills
14 yr old male received a Pfizer 5-11 yr old dose (0.2mL) during a mass vaccine clinic.  No adverse outcomes noted or reported.